Search Results for citation:"89 FR 99827"

Found 3 results
Skip to main content

Search Results: citation:"89 FR 99827"

  • Type:Notice
    Citation:89 FR 99827
    Reading Time:less than a minute

    Boehringer Ingelheim Animal Health Puerto Rico LLC submitted a notification for proposed production at their facility in Barceloneta, Puerto Rico, within Subzone 61AC. The notification was reviewed by the Foreign-Trade Zones Board, which published an invitation for public comment in the Federal Register on August 14, 2024. On December 6, 2024, the Board decided that no further review was needed and authorized the production activity as described, following their regulations. The decision is noted in Federal Register document number 2024-29086.

    Simple Explanation

    Boehringer Ingelheim Animal Health Puerto Rico got permission to make animal medicine in Barceloneta, Puerto Rico, after officials checked and said it was okay to start without more reviews.

  • Type:Notice
    Citation:89 FR 99827
    Reading Time:about 4 minutes

    The U.S. Department of Commerce has concluded an expedited sunset review regarding steel wire garment hangers from China. They determined that if the current antidumping duty order is revoked, dumping is highly likely to continue or reoccur, with possible dumping margins as high as 187.25%. This review aims to protect U.S. manufacturers from unfair pricing practices by foreign companies. The results and related information on this matter can be accessed online for further details.

    Simple Explanation

    The U.S. government checked if it should keep a special rule to stop clothes hangers from China from being sold in America at too low a price. They found that if they removed this rule, companies in China might start selling the hangers for too cheap again, which can be unfair to American companies.

  • Type:Notice
    Citation:89 FR 99827
    Reading Time:less than a minute

    Curia New York, Inc., a subsidiary of Curia Global, Inc., has received authorization to carry out production activities in its location in Rensselaer, New York, which is classified as Subzone 121A of the Foreign-Trade Zone. This authorization follows a notification submitted on August 8, 2024, and a public comment period that was announced in the Federal Register. On December 6, 2024, the FTZ Board decided no further review was needed, allowing Curia New York to proceed with their activities according to the regulations of the FTZ Board.

    Simple Explanation

    Curia New York got the green light to make special ingredients for medicine at their place in New York called Subzone 121A. After checking with the public and making sure everything was okay, they don't need any more approvals to start their work there.